• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number VBHR060502W
Device Problem Migration (4003)
Patient Problem Failure of Implant (1924)
Event Date 02/06/2024
Event Type  Injury  
Manufacturer Narrative
A1: no patient specific details have been provided.Therefore, the patient initials reflect the w.L.Gore internal case number.H6: code c19 - a review of the manufacturing records indicated the lot met pre-release manufacturing specifications.Code c21 - the device was returned to w.L.Gore and it is under engineering evaluation.Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
It was reported to gore that on (b)(6) 2024, a patient was to be implanted with a 6mm x 5cm gore® viabahn® endoprosthesis with heparin bioactive surface (vsx device) to treat the external carotid artery aneurysm.The device moved during the deployment process.The device was removed via open surgery.
 
Manufacturer Narrative
H6: code c19 - evaluation of received items: a) the returned device was determined to be consistent with the product listed within the complaint by means of labelling and device features.The delivery system was returned with no endoprosthesis mounted on the distal end of the catheter.A kink was observed on the distal shaft adjacent to the transition.An assessment of deployment performance was not possible with the items returned for evaluation.B) two photos were submitted by the field for review with similar content and field of view.The images were reviewed as part of the investigation and are consistent with the information gathered during the engineering evaluation.The images demonstrate a viabahn® device with a blue 0.035¿ compatible catheter labeled at the hub as a 6 mm x 5 cm stent-graft configuration.The device appears deployed with no endoprosthesis mounted on the distal shaft.No further information was obtained from the evaluation of the images.Code d15 - the reported primary device failure, related to partial deployment with partial expansion of the endoprosthesis, could not be independently confirmed with the items submitted for review.An independent assessment of deployment performance could not be conducted as the viabahn® device was returned deployed with no endoprosthesis present.The investigation could not establish the cause of the reported hazardous situation nor assign a primary device failure mode.The reported device failure concerning device movement during deployment could not be independently confirmed with the items available for review.The field reported device movement occurred after the physician had pulled on the deployment line with higher force.Therefore, the root cause of the deployment inaccuracy is consistent with use error as reported (i.E., user forcefully pulls the deployment knob and does not deploy in a smooth and consistent motion).The ifu instructs users to slowly pull the deployment knob during deployment of the viabahn® device and minimize catheter movement to ensure accurate positioning of the endoprosthesis.The field reported the viabahn® device was removed following surgical conversion; however, the root cause of the removal could not be identified with the available information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
qiong wang
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key18956722
MDR Text Key338305141
Report Number2017233-2024-04732
Device Sequence Number1
Product Code NIP
Combination Product (y/n)Y
Reporter Country CodeCH
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/21/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberVBHR060502W
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/21/2024
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/05/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/17/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age58 YR
Patient SexMale
Patient Weight65 KG
-
-